Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening

BACKGROUND: Newborn screening (NBS) for sickle cell disease incidentally identifies heterozygous carriers of hemoglobinopathy mutations. In Ontario, Canada, these carrier results are not routinely disclosed, presenting an opportunity to investigate the potential health implications of carrier status...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pediatr
Main Authors: Khangura, Sara D., Potter, Beth K., Davies, Christine, Ducharme, Robin, Bota, A. Brianne, Hawken, Steven, Wilson, Kumanan, Karaceper, Maria D., Klaassen, Robert J., Little, Julian, Simpson, Ewurabena, Chakraborty, Pranesh
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247172/
https://ncbi.nlm.nih.gov/pubmed/34210267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-021-02751-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados